Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6». (2021). Voprosy Onkologii, 67(3), 368-373. https://doi.org/10.37469/0507-3758-2021-67-3-368-373